ClinicalTrials.gov
public full text
Public Domain
Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy
This expanded access study is designed to provide RAD001 to patients with MRCC who are without satisfactory treatment alternatives, until RAD001 becomes commercially available.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Bortezomib in Treating Patients With Metastatic Kidney Cancer#880773
- Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid Tumors#875360
- AE-941 in Treating Patients With Metastatic Kidney Cancer#992718
- A Study of DC05F01 in Chinese Patients with Advanced or Metastatic Solid Tumors#1153591
- SU011248 for Platinum-Refractory Urothelial Cancer Evaluation Trial#831401
Record · ID 906092
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive